James Laforce Net Worth

The estimated Net Worth of James Laforce is at least $25.7 Thousand dollars as of 9 December 2005. James Laforce owns over 600 units of BlackRock Health Sciences Trust stock worth over $25,302 and over the last 21 years James sold BME stock worth over $360.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

James Laforce BME stock SEC Form 4 insiders trading

James has made over 5 trades of the BlackRock Health Sciences Trust stock since 2003, according to the Form 4 filled with the SEC. Most recently James bought 600 units of BME stock worth $7,818 on 9 December 2005.

The largest trade James's ever made was buying 600 units of BlackRock Health Sciences Trust stock on 9 December 2005 worth over $7,818. On average, James trades about 16 units every 9 days since 2003. As of 9 December 2005 James still owns at least 600 units of BlackRock Health Sciences Trust stock.

You can see the complete history of James Laforce stock trades at the bottom of the page.

What's James Laforce's mailing address?

James's mailing address filed with the SEC is C/O BLACKROCK FINANCIAL MANAGEMENT, INC., 40 EAST 52ND STREET, NEW YORK, NY, 10022.

Insiders trading at BlackRock Health Sciences Trust

Over the last 19 years, insiders at BlackRock Health Sciences Trust have traded over $27,424 worth of BlackRock Health Sciences Trust stock and bought 5,012 units worth $181,509 . The most active insiders traders include Ralph Schlosstein, Jerrold B Harris, and Karen P Robards. On average, BlackRock Health Sciences Trust executives and independent directors trade stock every 203 days with the average trade being worth of $147,131. The most recent stock trade was executed by Kyle Mc Clements on 31 January 2024, trading 625 units of BME stock currently worth $26,356.

What does BlackRock Health Sciences Trust do?

blackrock's business is investing on behalf of our clients, from large institutions to parents and grandparents, doctors and teachers who entrust their savings to us. we work only for our clients—period. our promise is to offer them the clearest thinking about what to do with their money and the products and services they need to secure a better financial future. that's why investors of all kinds have made us the world’s largest asset manager, entrusting us with trillions of dollars, and it’s why companies, institutions and global governments come to us for help meeting their biggest financial challenges. important disclosures: http://www.blackrock.com/corporate/en-us/compliance/social-media-guidelines

Complete history of James Laforce stock trades at Arena Pharmaceuticals Inc, Blackrock & Resources Trust, BlackRock Floating Rate Income Trust, BlackRock Core Bond Trust, BlackRock Municipal 2020 Term Trust, BlackRock Income Trust Inc, BlackRock Enhanced Global Dividend Trust, BlackRock Enhanced Equity Dividend Trust, and BlackRock Health Sciences Trust

BlackRock Health Sciences Trust executives and stock owners

BlackRock Health Sciences Trust executives and other stock owners filed with the SEC include:

• Dr. Erin Xie Ph.D.,
  Portfolio Mang.
• Thomas P. Callan C.F.A.,
  Portfolio Mang.
• Dr. Xiang Liu Ph.D.,
  Portfolio Mang.
• Jeffrey Gene Lee,
  Portfolio Mang.
• Christopher M. Accettella,
  Portfolio Mang.
• Dr. Erin Xie,
  Portfolio Mang.
• Kyle G. McClements CFA,
  Portfolio Mang.
• Thomas P. Callan C.F.A., CFA,
  Portfolio Mang.
• Charles Choon Sik Park,
  Chief Compliance Officer and Anti-Money Laundering Officer
• Xiang Liu,
  
• Jerrold B Harris,
  Director
• Richard Cavanagh,
  Director
• Robert Glenn Hubbard,
  Director
• Christopher Accettella,
  
• Michael J Castellano,
  Director
• Catherine A. Lynch,
  Director
• Karen P Robards,
  Director
• Kyle Mc Clements,
  
• H Erin Xie,
  
• W Carl Kester,
  Director
• James Laforce,
  Director
• Walter F Mondale,
  Director
• Ralph Schlosstein,
  Director
• Frank Fabozzi,
  Director
• Kathleen F Feldstein,
  Director
• James T Flynn,
  Director
• George Nicholas Iii Beckwith,
  Director
• Robert Kapito,
  President & CEO of the Trust
• Henry Gabbay,
  Director
• Dick Davis,
  Director
• Kent Dixon,
  Director
• Cynthia Egan,
  Director
• Jeffrey Gene Lee,